UPDATED 20.02.2014 11:08

Organised cervical cancer screening programme in the Helsinki and Uusimaa health care district in Finland in the invitation year 2008. Numbers and percentage distribution of primary screening test results, referrals for further examinations, and histological diagnosis of the cervix uteri.

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 18893 238 1.26 1 0.01 1 0.01 4 0.02 7 0.04 52 0.28 18 0.10 155 0.82
I 17115 - - - - - - - - - - - - - - - -
II 1605 65 0.34 - - - - - - 1 0.01 3 0.02 3 0.02 58 0.31
III 164 164 0.87 1 0.01 1 0.01 1 0.01 5 0.03 46 0.24 14 0.07 96 0.51
IV 8 8 0.04 - - - - 3 0.02 1 0.01 3 0.02 1 0.01 - -
V 1 1 0.01 - - - - - - - - - - - - 1 0.01
Inadequate - - - - - - - - - - - - - - - - -
Unknown - - - - - - - - - - - - - - - - -
HPV test 9162 228 2.49 - - - - 6 0.07 12 0.13 60 0.65 22 0.24 128 1.40
Negative1 8053 2 0.02 - - - - - - - - - - - - 2 0.02
Positive2 1109 226 2.47 - - - - 6 0.07 12 0.13 60 0.65 22 0.24 126 1.38
Total 28055 466 1.66 1 0.00 1 0.00 10 0.04 19 0.07 112 0.40 40 0.14 283 1.01

1 Women with Papanicolaou class I or II negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.